From January 1, 2024 to March 31, 2024, the company has repurchased 10,300,000 shares, representing 0.5% for $1,000 million. With this, the company has completed the repurchase of 53,857,720 shares, representing 2.6% for $5,355.51 million under the buyback announced on July 18, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.89 CHF | +0.56% | +0.43% | +10.63% |
May. 16 | Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15 | DP |
May. 16 | Novartis: presents results of tender offer for MorphoSysy | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.63% | 209B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+9.32% | 169B | |
-0.80% | 162B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Tranche Update on Novartis AG's Equity Buyback Plan announced on July 18, 2023.